Suction Based Characterization of Healthy and Diseased Skin

NCT ID: NCT03644225

Last Updated: 2023-05-09

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

67 participants

Study Classification

INTERVENTIONAL

Study Start Date

2018-06-11

Study Completion Date

2019-06-04

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The mechanical properties of healthy and SSc-diseased skin will be assessed by suction based measurements. The negative pressure needed to gain a certain tissue elevation, tissue elevation in response to a certain negative pressure as well as the time of retraction of tissue will be recorded and analyzed. Mesurments will be done with the new developed Aspiration Device\_Nimble and with the CE-certified Cutometer MPA 580.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Patients with systemic sclerosis (SSc) show a thickening of the skin due to massive deposition of collagen and temporary edema in the dermis. The clinical palpation method is currently the only diagnosis method. For an objective detection a non-invasive skin elasticity measurement can be performed. The widely used approach is based on local tissue suction. This study aims at an identification and quantification of mechanical and structural properties of human skin. The results will then be compared in age- and gender matched control groups. For evaluation of the skin elasticity measurement the results will be compared to the clinical parametar validated, modified Rodnan skin score (mRSS).

The mechanical properties of healthy and diseased skin will be assessed by suction based measurements. The negative pressure is needed to gain a certain tissue elevation. Tissue elevation in response to a certain negative pressure as well as the time of retraction of tissue will be recorded and analyzed. (The different parameters depend on

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Systemic Sclerosis

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NON_RANDOMIZED

Intervention Model

PARALLEL

Primary outcome:

Mechanical characterization of healthy and diseased skin using novel aspiration device and comparing it to the already validated Cutometer® MPA 580. Comparison of mechanical skin properties of healthy to patients' skin tissue (control vs. examined group).

Secondary outcome:

Defining predictors of the skin worsening.
Primary Study Purpose

OTHER

Blinding Strategy

NONE

No randomisation

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Healthy Control

Healthy controls, who signed an informed consent, age ≥18 years old will be age and sex matched to the SSc patients

Group Type OTHER

Measurment with Aspirational Medical Device

Intervention Type DEVICE

The mechanical properties of healthy and SSc-diseased skin will be assessed by suction based measurements with a new developed Aspirational Medical Device.

Measurment with Cutometer MPA 580

Intervention Type DEVICE

The mechanical properties of healthy and SSc-diseased skin will be assessed by CE-marked Cutometer MPA 580

Systemic sclerosis patients

SSc patients who signed an Informed consent

* Age ≥18 years old
* Diagnosis of systemic sclerosis according to the ACR/EULAR 2013 criteria
* Skin thickening diagnosed by clinical expert

Group Type OTHER

Measurment with Aspirational Medical Device

Intervention Type DEVICE

The mechanical properties of healthy and SSc-diseased skin will be assessed by suction based measurements with a new developed Aspirational Medical Device.

Measurment with Cutometer MPA 580

Intervention Type DEVICE

The mechanical properties of healthy and SSc-diseased skin will be assessed by CE-marked Cutometer MPA 580

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Measurment with Aspirational Medical Device

The mechanical properties of healthy and SSc-diseased skin will be assessed by suction based measurements with a new developed Aspirational Medical Device.

Intervention Type DEVICE

Measurment with Cutometer MPA 580

The mechanical properties of healthy and SSc-diseased skin will be assessed by CE-marked Cutometer MPA 580

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

-Signed Informed Consent

Healthy volunteers:

\- Age ≥18 years old

SSc-Patients:

* Age ≥18 years old
* Diagnosis of systemic sclerosis according to the ACR/EULAR 2013 criteria
* Skin thickening diagnosed by clinical expert

Exclusion Criteria

* Known or suspected non-compliance, drug or alcohol abuse,
* Inability to follow the procedures of the study, e.g. due to language problems, psychological disorders, dementia, etc. of the participant,
* Previous enrolment into the current study,
* Participants, who are unable to hold still
* Impaired skin at the regions of measurements
Minimum Eligible Age

18 Years

Maximum Eligible Age

65 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Swiss Federal Institute of Technology

OTHER

Sponsor Role collaborator

Oliver Distler

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Oliver Distler

Prof.Dr.med.Oliver Distler, Director of the Department of Rhumatology, University Hospital Zurich

Responsibility Role SPONSOR_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Oliver Distler, Prof.Dr.med

Role: PRINCIPAL_INVESTIGATOR

Department of Rheumatology

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Department of Rheumatology, University Hospital Zurich

Zurich, , Switzerland

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Switzerland

References

Explore related publications, articles, or registry entries linked to this study.

Muller B, Ruby L, Jordan S, Rominger MB, Mazza E, Distler O. Validation of the suction device Nimble for the assessment of skin fibrosis in systemic sclerosis. Arthritis Res Ther. 2020 Jun 3;22(1):128. doi: 10.1186/s13075-020-02214-y.

Reference Type DERIVED
PMID: 32493508 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

2017-01154

Identifier Type: OTHER

Identifier Source: secondary_id

Swissmedic:2017-MD_0045

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Swiss Itch Registry
NCT06120907 RECRUITING